Abiomed-img-body-heart

Advances in
Hemodynamic
Support

January 23-24, 2014

Loews Miami Beach Cowrie Room and Foyer, 3rd Floor
1601 Collins Ave
Miami Beach, FL

Sponsored by Cardiovascular Research Foundation
Supported through an educational grant from ABIOMED, INC.

Only attending US and Canadian licensed physicians are eligible to participate.

Overview

CRF Invites You to Participate in: Advances in Hemodynamic Support: an Interactive Discussion about Clinical Indications and Use.

Along with my program co-chairs, Drs. John Lasala and Ajay Kirtane and the Cardiovascular Research Foundation, I would like to invite you to participate in this interactive, one and a half-day program discussing the evolving treatments of hemodynamically compromised patients requiring cardiovascular intervention. The sessions will take place January 23-24, 2014 at the Loews Hotel in Miami, FL and the findings of the sessions will be published on TCTMD after the conference’s completion.

In exchange for your active participation in this program, CRF will provide complimentary flight and hotel for all participants. There are a limited number of seats available so please register now.

Best regards,

Jeffrey W. Moses, MD

This course is not accredited for Continuing Medical Education (CME)

Learning Objectives

At the end of this program, the attendees will be able to:

  • Analyze hemodynamic support strategies in high-risk patients not eligible for surgery
  • Compare evidence for percutaneous mechanical circulation support devices in cardiogenic shock
  • Discuss cases where percutaneous ventricular assist devices (PVAD) were used
  • Identify tips and tricks for reducing complications and circulatory support device management

Target Audience

This educational activity is designed for practicing US interventional cardiologists and clinical cardiologists involved in the management of patients with cardiovascular disease requiring hemodynamic support.

Activity Evaluation

Evaluation will address content, presentation, possible bias, and future educational needs.

Program Sponsorship and Support

This program is sponsored by the Cardiovascular Research Foundation and funded through an educational grant from ABIOMED, Inc. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from the commercial supporter.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty.

Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.

Abiomed-img-body-heart_2

Advances in Hemodynamic Support

Faculty

CHAIRS

Jeffrey W. Moses, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Ajay J. Kirtane, MD, SM
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

John M. Lasala, MD, PhD
Washington University School of Medicine St. Louis, MO

FACULTY

Nirat Beohar, MD
Columbia University Division of Cardiology at Mt. Sinai Medical Center
Miami, FL

Daniel Burkhoff, MD, PhD
Columbia University Medical Center
New York, NY

William W. O’Neill, MD
Henry Ford Hospital
Detroit, MI

Nir Uriel, MD
NewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

George W. Vetrovec, MD
Virginia Commonwealth University
Medical Center
Richmond, VA

Agenda

Thursday, January 23, 2014

6:00 pm

Registration

6:30 pm

Reception

7:00 pm

Open Case Discussions over Dinner: Roundtable Presentations

9:00 pm

Adjourn

Friday, January 24, 2014

7:30 am

Breakfast

8:00 am

Welcome and Course Goals
Jeffrey W. Moses

8:10 am

Advisory Poll of Institutional Preferences in PMCS

8:15 am

Hemodynamics of Cardiac Decompensation and Mechanical Circulatory Support (MCS)
Daniel Burkhoff

9:00 am

The Spectrum of Available Percutaneous Devices for MCS
John M. Lasala

9:30 am

Discussion on Setting Up Institutional Programs for MCS

9:45 am

Break

Moderators: Jeffrey W. Moses, William O’Neill

9:55 am

Advisory Poll on Case Selection for Prophylactic Support

10:00 am

Defining the Appropriate Patient for MCS
George W. Vetrovec

10:15 am

What Is an Optimal Strategy for High-Risk Patients? A Look at the Evidence
Jeffrey W. Moses

10:30 am

Description of and Current Evidence for IABP and Nonaxial Support Devices
Ajay J. Kirtane

10:45 am

Ongoing Lessons from the PROTECT 2 Trial
William O’Neill

11:00 am

Case Presentations: A High-Risk Case with Hemodynamic Collapse and Salvage and a High-Risk Case Where Collapse Was Avoided
Panel

11:20 am

Discussion on Case Selection for Prophylactic Support

11:45 pm

Lunch Break

Moderators: Ajay J. Kirtane, John Lasala

12:45 pm

Advisory Poll on PMCS and Revascularization in Cardiogenic Shock

12:50 pm

Definition of the Syndrome and Goals of Therapy (Including Revascularization)
George W. Vetrovec

1:05 pm

Current Evidence of Treatment of Cardiogenic Shock with Axial Flow Support
Jeffrey W. Moses

1:20 pm

Other Percutaneous Support Modalities in Cardiogenic Shock: A Review of the Evidence
Ajay J. Kirtane

1:35 pm

When LVAD Is Not Enough: Migration to Biventricular Support, Adding ECMO to PVAD
Nir Uriel

1:50 pm

Case Presentations: Cardiogenic Shock with PVAD to Recovery and Cardiogenic Shock with PVAD to Destination Therapy
Panel

2:10 pm

Discussion on Cardiogenic Shock and Indications for PMCS

2:30 pm

Break

Moderators: Jeffrey W. Moses, Ajay J. Kirtane

2:45 pm

Expanded Uses of PMCS: Valvuloplasty, Aortic Stenosis, and VT
Nirat Beohar, MD

3:00 pm

Tips and Tricks of Patient and Device Management
John M. Lasala

3:25 pm

Top 3 Cases with Panel Discussion

4:00 pm

Advisory Poll: What Did We Learn?

4:15 pm

Future Directions of Percutaneous MCS: Clinical Targets and Advanced Technologies
Nir Uriel

4:45 pm

Summary and Questions

5:00 pm

Adjourn